The suggestion that there is a connection between chronic intraprostatic inflammation and prostate cancer was declared some years ago. As Toll-like receptors (TLRs) are the key players in the processes of chronic intraprostatic inflammation, there is a hypothesis that TLR gene polymorphisms may be associated with prostate cancer risk. Although a number of comprehensive studies have been conducted on large samples in various countries, reliable connections between these single nucleotide polymorphisms and prostate cancer risk, stage, grade, aggressiveness, ability to metastasize, and mortality have not been detected. Results have also varied slightly in different populations. The data obtained regarding the absence of connection between the polymorphisms of the genes encoding interleukin-1 receptor-associated kinases (IRAK1 and IRAK4) and prostate cancer risk might indicate a lack of association between inherited variation in the TLR signaling pathway and prostate cancer risk. It is possible to consider that polymorphisms of genes encoding TLRs and proteins of the TLR pathway also do not play a major role in the etiology and pathogenesis of prostate cancer. Feasibly, it would be better to focus research on associations between TLR single nucleotide polymorphisms and cancer risk in other infection-related cancer types.
Discussion
The results of a number of studies investigating the connections between sexually transmitted infections and prostatitis, between prostatitis and prostate cancer, and between genetic and circulating markers of inflammation and response to infection all support the hypothesis that there is a connection between chronic intraprostatic inflammation and prostate cancer. 1 The list of causes of such inflammation includes exposure to various infectious agents, autoimmune disorders, damage from mechanical injuries, and chemical carcinogens (as exogenous as endogenous, for instance, certain hormones). 1 Toll-like receptors (TLRs) constitute a family of receptors that recognize pathogenassociated and damage-associated molecular patterns, consequently playing a key role in innate and adaptive immune response, initiating the aforementioned inflammation. It has been suggested that TLR gene polymorphisms may affect TLR signaling, and, as a consequence, may influence TLR-mediated immune response, modulating prostate cancer risk. 2 Since 2004, when Zheng et al 2 published the first paper devoted to the investigation of the role of TLR single nucleotide polymorphisms (SNPs) in cancer etiology, a number of other studies on this subject have been carried out. Nevertheless, results are rather discouraging: although Zheng et al 2 found the rs11536889 polymorphism is associated with increased prostate cancer risk and Chen et al 3 [2] [3] [4] 6, 7, 11, 13, 14 The active investigation of a correlation between TLR SNPs and prostate cancer is intriguing. Despite there being some fundamental mechanisms that indicate TLR gene polymorphisms may play a role in prostate cancer etiology, and despite there being a number of comprehensive studies conducted ). However, Lindström et al's 7 meta-analysis, in which all of the populations mentioned above were considered, revealed that TLR gene polymorphisms cannot be the markers of prostate cancer overall and therefore they should be considered as risk markers, even in populations where the association has been found. 7 Apparently, the lack of sample size was not the reason for negative results in either the general meta-analysis or in specific studies in particular populations, because the investigations in Swedish, 2,4,15 European, 5 and US populations 3, 6, 8, 10, 12 included a large number of case and control subjects. Although two Korean studies 11, 13 had relatively small sample sizes, a recent large study in the Korean population also (meta-analysis of Sun et al, 4 Chen et al, 6 and Yeager et al 5 obtained negative results. 14 Therefore, the statistical power of almost all of the studies was sufficient. Population stratification in various studies revealed no subcategorical differences when compared with general results, although a dependence of association on age was found in one study in the Swedish population, 2 and cholesterol level was found to influence the association in one study in the US population. 12 However, alone these results cannot provide sufficient information on the subcategorical modification of association of TLR gene polymorphisms with prostate cancer. In addition, there are no studies considering the gene-gene and gene-environment interactions in relation to prostate cancer.
Sun et al 15 did not observe any correlation between polymorphisms of the genes encoding the interleukin-1 receptor-associated kinases (IRAK1 and IRAK4) and prostate cancer. The data obtained by Sun et al 15 might also reflect a lack of association between inherited variation in genes encoding proteins of the TLR signaling pathway and prostate cancer risk, since IRAK1 and IRAK4 are key proteins of this pathway.
Conclusion
In conclusion, it is possible to suggest that TLR and TLR pathway gene polymorphisms do not play a major role in the etiology of prostate cancer, although in certain populations their minor role can be established. Feasibly, it would be better to focus research on associations between TLR SNPs and cancer risk in other infection-related cancer types. 
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